최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.17 no.6 = no.86, 2007년, pp.841 - 846
이상률 (부산대학교 의과대학 생화학 교실)
종양항원의 동정과 발견은 암 백신 및 진단개발에 매우 중요하다. 암환자의 혈청에서 종양 항원를 동정하는 SEREX가 개발되어왔다. SEREX에서 동정된 종양항원은 진단의 분자 지표 뿐 만 아니라 항암 백신 개발에 응용되고 있다. 따라서 SEREX는 종양항원 동정에 사용되어지는 매우 강력한 방법이다. 항암 백신의 개발은 동정된 종양항원이 체 또는 T cell에 기초하여 작동하는지 해명하는 것이 중요한 요소이다. 이 논문은 강력한 종양항원의 동정 방법인 SEREX 의 응용에 관하여 고찰 할 것이다.
The identification of tumor antigens is essential for the development of anticancer therapeutic vaccines and clinical diagnosis of cancer. SEREX (serological analysis of recombinant cDNA expression library)has been used to identify such tumor antigens by screening sera of cancer patients with cDNA e...
Brass, N., D. Heckel, U. Sahin, M. Pfreundschuh, G. W. Sybrecht, E. Meese. 1997. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum. Mol. Genet. 6, 33-39
Cancer Immunome database: http://www2.licr.org/ CancerImmunomeDB
Chen, Y. T., M. J. Scanlan, Y. Obata and L. J. Old(2000) Identification of human tumor antigens by serological expression cloning. In:S. A. Rosenberg (ed.). Principles and Practice of Biologic Therapy of Cancer, pp. 557- 570. Philadelphia: Lippincott Williams & Wilkins
Fernandez-Madrid, F., P. J. VandeVord, X. Yang, R. L. Karvonen, P. M. Simpson, M. J. Kraut, J. L. Granda and J. E. Tomkiel. 1999. Antinuclear antibodies as potential markers of lung cancer. Clin. Cancer Res. 5, 1393-1400
Ishikawa, T., T. Fujita, Y. Suzuki, S. Okabe, Y. Yuasa, T. Iwai and Y. Kawakami. 2003. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. Cancer Res. 63, 5564-5572
Jager, D., M. Unkelbach, C. Frei, F. Bert, M. J. Scanlan, E. Jager, L. J. Old, Y. T. Chen and A. Knuth, 2002. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun. 2, 5-9
Jager, E., Y. T. Chen, J. W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jager, M. Arand, H. Wada, Y. Noguchi, E. Stockert, L. J. Old and A. Knuth. 1998. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187, 265-270
Jeoung, D. I., E. B. Lee, S. Lee, Y. Lim, D. Y. Lee, J. Kim, H. Y. Kim and Y. W. Song. 2002. Autoantibody to DNA binding protein B as a novel serologic marker in systemic sclerosis. Biochem. Biophys. Res. Commun. 299, 549-554
Koslowski, M., O. Tureci, C. Bell, P. Krause, H. A. Lehr, J. Brunner, G. Seitz, F. O. Nestle, C. Huber and U. Sahin. 2002. Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res. 62, 6750-6755
Krause, P., O. Tureci, P. Micke, R. Buhl, C. Huber and U. Sahin. 2003. SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity. J. Immunol. Methods 283, 261-267
Lagarkova, M. A., E. P. Koroleva, D. V. Kuprash, V. E. Boitchenko, U. A. Kashkarova, S. A. Nedospasov and Y. V. Shebzukhov. 2003. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA). Immunol. Lett. 85, 71-74
Lee, S. Y., Y. Obata, M. Yoshida, E. Stockert, B. Williamson, A. A. Jungbluth, Y. T. Chen, L. J. Old and M. J. Scanlan. 2003. Immunomic analysis of human sarcoma. Proc. Natl. Acad. Sci. USA. 100, 2651-2656
Lee, S. Y., B. Williamson, O. L. Caballero, Y. T. Chen, M. J. Scanlan, G. Ritter, C. V. Jongeneel, A. J Simpson and L. J. Old. 2004. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immun. 17, 4:13
Mischo, A., A. Wadle, K. Watzig, D. Jager, E. Stockert, D. Santiago, G. Ritter, E. Regitz, E. Jager, A. Knuth, L. Old, M. Pfreundschuh and C. Renner. 2003. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. Cancer Immun. 3, 5
Novellino, L., N. Renkvist, F. Rini, A. Mazzocchi, L. Rivoltini, A. Greco, P. Deho, P. Squarcina, P. F. Robbins, G. Parmiani and C. Castelli. 2003. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen. J. Immunol. 170, 6363-6370
Old, L. J. 2003. Cancer vaccines 2003: opening address. Cancer Immun. 3(2), 1
Pascolo, S., M. Schirle, B. Guckel, T. Dumrese, S. Stumm, S. Kayser, A. Moris, D. Wallwiener, H. G. Rammensee, S. A. Stevanovic. 2001. MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. Cancer Res. 15, 4072-4077
Sahin, U., O. Tureci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, ,F. Stenner, G. Luo, I. Schobert and M. Pfreundschuh, 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA. 92, 11810-11813
Sakakura, C., K. Hasegawa, K. Miyagawa, S. Nakashima, T. Yoshikawa, S. Kin, Y. Nakase, S. Yazumi, H. Yamagishi, T. Okanoue, T. Chiba and A. Hagiwara. 2005. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin. Cancer Res. 11, 6479-6488
Salazar, L. G., J. Fikes, S. Southwood, G. Ishioka, K. L.Knutson, T. A. Gooley, K. Schiffman and M. L. Disis. 2003. Immunization of cancer patients with HER-2/neuderived peptides demonstrating high-affinity binding to multiple class II alleles. Clin. Cancer Res. 9, 5559-5565
Scanlan, M. J, I. Gout, C. M. Gordon, B. Williamson, E. Stockert, A. O. Gure, D. Jager, Y. T. Chen, A. Mackay, M. J. O'Hare and L. J. Old. 2001. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun. 1, 4
Scanlan, M. J., A. J. Simpson and L. J. Old, 2004. The cancer/ testis genes: review, standardization, and commentary. Cancer Immun. 4, 1
Scanlan, M. J., S. Welt, C. M. Gordon, Y. T. Chen, A. O. Gure, E. Stockert, A. A. Jungbluth, G. Ritter, D. Jager, E. Jager, A. Knuth and L. J. Old. 2002. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res. 62, 4041-4047
Schiavetti, F., J. Thonnard, D. Colau, T. Boon and P. G. Coulie, 2002. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res. 62, 5510-5516
Simpson, A. J, O. L Caballero, A. Jungbluth, Y. T. Chen and L. J. Old. 2005. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 5, 615-625
Thomas, C.M., C.G. Sweep, Int. J. Biol. 2001. Markers, Serum tumor markers: past, state of the art, and future. Int J Biol Markers. 16, 73-86. Review
van der, B. P., Y. Zhang, P. Chaux, V. Stroobant, C. Panichelli, E. S. Schultz, J. Chapiro, B. J. Van Den Eynde, F. Brasseur and T. Boon, 2002. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol. Rev. 188, 51-64
van Nimwegen, M.J., M. Huigsloot, A. Camier, I.B. Tijdens, B. van de Water 2006. Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol. Pharmacol. 70, 1330-1339
Watson S. A, T. M Morris, D. F McWilliams, J Harris, S Evans, A Smith, P. A. Clarke, 2003. Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. Br. J. Cancer 88, 1065-1070. R
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.